Assess the Safety, Tolerability, and Pharmacokinetics of AZD6234 Following Single Ascending Dose Administration to Healthy Subjects Who Are Overweight or Obese

Status:
Not yet recruiting

Trial end date:
2023-05-09

Target enrollment:

Participant gender:

A study in healthy male and female participants of non-childbearing potential who are overweight or obese.

Phase 1

AstraZeneca

Acetaminophen